ViOptix

About:

ViOptix, a biotech company, manufactures innovative proprietary products for tissue oximetry–measuring oxygen saturation levels in tissues.

Website: http://www.vioptix.com

Twitter/X: vioptixinc

Top Investors: Vivo Capital, Morningside Venture Investments, Morningside Group, Thrivent, MDS Capital

Description:

ViOptix Inc. develops, manufactures and markets innovative proprietary products for tissue oximetry, measuring oxygen saturation levels in tissues. The Company's products and products under development consist of near infrared generators and single-use disposable sensor devices. Its first product, the ODISsey System, received U.S. Food and Drug Administration clearance in January 2005 for the measurement of localized tissue oxygenation levels for critical care applications. For more information on the Company or its products, visit the Company's website at http://www.vioptix.com.

Total Funding Amount:

$27.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Fremont, California, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)vioptix.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2010-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai